Cargando…

T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy

T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and...

Descripción completa

Detalles Bibliográficos
Autores principales: Frank, Meredith L., Lu, Kaylene, Erdogan, Can, Han, Yi, Hu, Jian, Wang, Tao, Heymach, John V., Zhang, Jianjun, Reuben, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011887/
https://www.ncbi.nlm.nih.gov/pubmed/36413126
http://dx.doi.org/10.1158/1078-0432.CCR-22-2469
_version_ 1784906499604086784
author Frank, Meredith L.
Lu, Kaylene
Erdogan, Can
Han, Yi
Hu, Jian
Wang, Tao
Heymach, John V.
Zhang, Jianjun
Reuben, Alexandre
author_facet Frank, Meredith L.
Lu, Kaylene
Erdogan, Can
Han, Yi
Hu, Jian
Wang, Tao
Heymach, John V.
Zhang, Jianjun
Reuben, Alexandre
author_sort Frank, Meredith L.
collection PubMed
description T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and of diseases like cancer. Next-generation sequencing technologies have greatly enabled the high-throughput analysis of the TCR repertoire. On the basis of our extensive experience in the field from the past decade, we provide an overview of TCR sequencing, from the initial library preparation steps to sequencing and analysis methods and finally to functional validation techniques. With regards to data analysis, we detail important TCR repertoire metrics and present several computational tools for predicting antigen specificity. Finally, we highlight important applications of TCR sequencing and repertoire analysis to understanding tumor biology and developing cancer immunotherapies.
format Online
Article
Text
id pubmed-10011887
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Association for Cancer Research
record_format MEDLINE/PubMed
spelling pubmed-100118872023-03-15 T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy Frank, Meredith L. Lu, Kaylene Erdogan, Can Han, Yi Hu, Jian Wang, Tao Heymach, John V. Zhang, Jianjun Reuben, Alexandre Clin Cancer Res Reviews T cells are integral components of the adaptive immune system, and their responses are mediated by unique T-cell receptors (TCR) that recognize specific antigens from a variety of biological contexts. As a result, analyzing the T-cell repertoire offers a better understanding of immune responses and of diseases like cancer. Next-generation sequencing technologies have greatly enabled the high-throughput analysis of the TCR repertoire. On the basis of our extensive experience in the field from the past decade, we provide an overview of TCR sequencing, from the initial library preparation steps to sequencing and analysis methods and finally to functional validation techniques. With regards to data analysis, we detail important TCR repertoire metrics and present several computational tools for predicting antigen specificity. Finally, we highlight important applications of TCR sequencing and repertoire analysis to understanding tumor biology and developing cancer immunotherapies. American Association for Cancer Research 2023-03-14 2022-11-22 /pmc/articles/PMC10011887/ /pubmed/36413126 http://dx.doi.org/10.1158/1078-0432.CCR-22-2469 Text en ©2022 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
spellingShingle Reviews
Frank, Meredith L.
Lu, Kaylene
Erdogan, Can
Han, Yi
Hu, Jian
Wang, Tao
Heymach, John V.
Zhang, Jianjun
Reuben, Alexandre
T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
title T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
title_full T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
title_fullStr T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
title_full_unstemmed T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
title_short T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
title_sort t-cell receptor repertoire sequencing in the era of cancer immunotherapy
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011887/
https://www.ncbi.nlm.nih.gov/pubmed/36413126
http://dx.doi.org/10.1158/1078-0432.CCR-22-2469
work_keys_str_mv AT frankmeredithl tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT lukaylene tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT erdogancan tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT hanyi tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT hujian tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT wangtao tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT heymachjohnv tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT zhangjianjun tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy
AT reubenalexandre tcellreceptorrepertoiresequencingintheeraofcancerimmunotherapy